Investigating the biological effects of socioeconomic adversity in cancer

David Füller

Clinical and Translational Discovery ›› 2024, Vol. 4 ›› Issue (2) : e284

PDF
Clinical and Translational Discovery ›› 2024, Vol. 4 ›› Issue (2) :e284 DOI: 10.1002/ctd2.284
COMMENTARY

Investigating the biological effects of socioeconomic adversity in cancer

Author information +
History +
PDF

Keywords

biology of socioeconomic adversity / cancer / clinical research / oncology / Social determinants of health / translational research

Cite this article

Download citation ▾
David Füller. Investigating the biological effects of socioeconomic adversity in cancer. Clinical and Translational Discovery, 2024, 4(2): e284 DOI:10.1002/ctd2.284

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

WardE, JemalA, CokkinidesV, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93.

[2]

PinheiroLC, Reshetnyak E, AkinyemijuT, PhillipsE, Safford MM. Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. Cancer. 2022;128(1):122-130.

[3]

KehmRD, Spector LG, PoynterJN, VockDM, Altekruse SF, OsypukTL. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival? Cancer. 2018;124(20):4090-4097.

[4]

CellaDF, OravEJ, KornblithAB, et al. Socioeconomic status and cancer survival. J Clin Oncol. 1991;9(8):1500-1509.

[5]

UngerJM, Moseley AB, CheungCK, et al. Persistent disparity: socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. J Clin Oncol. 2021;39(12):1339-1348.

[6]

HastertTA, Ruterbusch JJ, BeresfordSAA, SheppardL, WhiteE. Contribution of health behaviors to the association between area-level socioeconomic status and cancer mortality. Soc Sci Med. 2016;148:52-58.

[7]

GuptaA, WilsonLE, PinheiroLC, et al. Association of educational attainment with cancer mortality in a national cohort study of black and white adults: a mediation analysis. SSM Popul Health. 2023;24:101546.

[8]

BaumerY, Powell-Wiley TM. Interdisciplinary approaches are fundamental to decode the biology of adversity. Cell. 2021;184(11):2797-2801.

[9]

FüllerD, LiuC, KoY-A, et al. Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease. Eur J Prev Cardiol. 2023.

[10]

Eugen-OlsenJ, Andersen O, LinnebergA, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med. 2010;268(3):296-308.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

158

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/